In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

BACKGROUND: Immunotherapies, driven by immune-mediated antitumorigenicity, offer the potential for significant improvements to the treatment of multiple cancer types. Identifying therapeutic strategies that bolster antitumor immunity while limiting immune suppression is critical to selecting treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenner, Adrianne L, Cassidy, Tyler, Belaid, Katia, Bourgeois-Daigneault, Marie-Claude, Craig, Morgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898884/
https://www.ncbi.nlm.nih.gov/pubmed/33608375
http://dx.doi.org/10.1136/jitc-2020-001387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898884/
https://www.ncbi.nlm.nih.gov/pubmed/33608375
http://dx.doi.org/10.1136/jitc-2020-001387

Ejemplares similares